Loading organizations...
Crista Galli Ventures operates as a specialist healthtech fund, investing in early-stage European startups. The firm focuses on deep tech, utilizing AI/ML in healthcare; digital health, with B2B/B2C patient solutions; and personalized medicine, integrating technology with genomics and microbiomes. This approach injects significant healthcare expertise into venture capital.
Dr. Fiona Pathiraja, a former NHS consultant radiologist, founded the firm in 2019 and serves as Managing Partner. Her insight centered on combining deep healthcare expertise with patient capital. This enables portfolio companies to navigate complex, regulated environments steadily, embedding industry understanding into their investment strategy.
The firm backs pan-European healthtech startups at Seed and Series A, also supporting under-represented founders through Crista Galli LABS. Crista Galli Ventures aims to shape health's future by empowering companies solving complex challenges through innovation. Their vision is to impact global health, advancing biological sciences for the coming century.
Crista Galli Ventures has 7 tracked investments across 7 companies. The latest tracked deal is $2.0M Seed in Surgery Hero in November 2022.